BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27932314)

  • 1. TIS21
    Lim IK; Choi JA; Kim EY; Kim BN; Jang S; Ryu MS; Shim SH
    Cell Signal; 2017 Jan; 30():179-190. PubMed ID: 27932314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
    Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
    Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
    Imran M; Lim IK
    Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
    Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
    Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
    Lim YB; Park TJ; Lim IK
    J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
    Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
    Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein.
    Choi OR; Ryu MS; Lim IK
    Cell Signal; 2016 Sep; 28(9):1172-1185. PubMed ID: 27208501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
    Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
    Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.
    Choi JA; Lim IK
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1657-65. PubMed ID: 23907596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIS21
    Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence.
    Demelash A; Pfannenstiel LW; Liu L; Gastman BR
    Oncotarget; 2017 Apr; 8(17):28154-28168. PubMed ID: 28423654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
    Imran M; Park TJ; Lim IK
    Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase 4 mediates ROS production in radiation-induced senescent cells and promotes migration of inflammatory cells.
    Sakai Y; Yamamori T; Yoshikawa Y; Bo T; Suzuki M; Yamamoto K; Ago T; Inanami O
    Free Radic Res; 2018 Jan; 52(1):92-102. PubMed ID: 29228832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN inhibits replicative senescence-induced MMP-1 expression by regulating NOX4-mediated ROS in human dermal fibroblasts.
    Noh EM; Kim JM; Hong OY; Song HK; Kim JS; Kwon KB; Lee YR
    J Cell Mol Med; 2017 Nov; 21(11):3113-3116. PubMed ID: 28557373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.
    Lim SK; Choi YW; Lim IK; Park TJ
    Clin Exp Metastasis; 2012 Dec; 29(8):901-13. PubMed ID: 22562501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
    Tirone F
    J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-Sensing Nox4 Generates Genotoxic ROS to Induce Premature Senescence of Nucleus Pulposus Cells through MAPK and NF-
    Feng C; Zhang Y; Yang M; Lan M; Liu H; Huang B; Zhou Y
    Oxid Med Cell Longev; 2017; 2017():7426458. PubMed ID: 29147462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα-Target Gene Expression Requires TIS21
    Hong AE; Ryu MS; Kim SJ; Hwang SY; Lim IK
    Mol Cells; 2018 Feb; 41(2):140-149. PubMed ID: 29385670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.